Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Evaluations and Price Targets for Sweetgreen NYSE SG

Elaine Mendonca by Elaine Mendonca
March 6, 2024
in Breaking News
0
MA stock news
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

Analysts have recently assessed Sweetgreen (NYSE: SG) and set a 12-month price target. The average target stands at $15.62, with a high estimate of $20.00 and a low estimate of $10.00, representing a 17.53% increase from the previous average price target of $13.29.

Various analyst actions have revealed differing sentiments towards Sweetgreen. Notably, analysts like Rahul Krotthapalli from JP Morgan and Christopher Carril from RBC Capital have upgraded their ratings to ‘Overweight’ and ‘Outperform,’ respectively, with price targets of $20.00. Conversely, Brian Harbour from Morgan Stanley has downgraded the rating to ‘Underweight’ with a price target of $11.00. These adjustments highlight the fluidity of analyst recommendations influenced by market conditions and company performance.

In conclusion, the recent analyst evaluations for Sweetgreen showcase a blend of bullish and bearish viewpoints, with price targets reflecting an overall optimistic outlook on the company’s future prospects.

SG Stocks Show Strong Performance on March 6, 2024: A Positive Sign for Investors

On March 6, 2024, SG stocks showed strong performance as they traded near the top of their 52-week range and above their 200-day simple moving average. The price change of SG shares increased by $0.62 since the market last closed, representing a 3.51% rise. The stock opened at $18.44 on March 6, which was $0.61 higher than its previous close, indicating a bullish start to the trading day for SG stocks. Investors and analysts may view the strong performance of SG stocks on March 6 as a positive sign for the company’s financial health and growth potential. Overall, the performance of SG stocks on March 6, 2024, demonstrates investor confidence and optimism in the company’s prospects. Investors should conduct their own research and analysis before making any investment decisions.

SG Stock Performance Review: Total Revenue Increases, Net Loss Improves, EPS Shows Mixed Results

On March 6, 2024, SG stock had a mixed performance based on the financial data provided by CNN Money. The company’s total revenue for the past year was $584.04 million, which represented a 24.24% increase compared to the previous year. However, the total revenue for the fourth quarter was $153.03 million, which remained flat compared to the previous quarter.

In terms of net income, SG reported a net loss of $113.38 million for the past year, which was a 40.46% improvement compared to the previous year. However, the net loss for the fourth quarter was $27.41 million, which represented a 9.42% decrease compared to the previous quarter.

Earnings per share (EPS) also showed a mixed performance for SG stock. The EPS for the past year was -$1.01, which represented a 41.41% improvement compared to the previous year. The EPS for the fourth quarter was -$0.24, which remained flat compared to the previous quarter.

Overall, SG stock showed signs of improvement in terms of total revenue and net income compared to the previous year. However, the company experienced a slight decrease in net income and flat earnings per share compared to the previous quarter. Investors should closely monitor the company’s performance in the upcoming quarters to assess its long-term growth potential.

Tags: SG
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
DrugRetailers Stock Market Today

Barnes Noble Education Earnings Report Preview Analysts Predict 001 EPS

Investings on laptop and finances

Anticipation Builds for Duckhorn Portfolios Quarterly Earnings Announcement

Analysts Bullish on CECO Environmentals Future Success

Recommended

Oracle Stock

Oracle Shares Face Sector-Wide Pressure Despite Solid Long-Term Chart

7 months ago
Telecommunications Industry stock Trading

Globalstar Forecasts Strong Financial Performance and Growth Initiatives for 2024

2 years ago
Pulmonx Corp Stock

Pulmonx Shares Surge on Leadership Shakeup and Upbeat Forecast

5 months ago
Healthcare-sector

Analysts Divided on GE HealthCare Technologies Evaluating the Potential of the Stock

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

Hesai Group’s Milestone Profit Tempered by Cautious Guidance

PagerDuty Charts a New Course with Autonomous AI Systems

Trending

Evolent Health Stock
AI & Quantum Computing

Evolent Health Bets on AI Leadership Amid Share Price Decline

by Jackson Burston
March 25, 2026
0

The healthcare technology company Evolent Health is making a strategic push into artificial intelligence, appointing a seasoned...

MongoDB Stock

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Talphera Stock

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026
Hain Celestial Stock

Hain Celestial Sheds Snack Division in Strategic Overhaul

March 25, 2026
Technology Select Sector SPDR® Fund Stock

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Evolent Health Bets on AI Leadership Amid Share Price Decline
  • MongoDB Strengthens Leadership Amid AI-Driven Growth Phase
  • Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com